glp-1 and autoimmune Receptor Agonists Diseases Exploring glucagon-like peptide-1 receptor agonists

12% average weight loss at 12 months for Teladoc Health members on a GLP-1 1 92% of Weight Management and Diabetes Prevention Program members continue their GLP-1 treatments after one year 2 98% of members taking a GLP-1 medication continue to engage after one year 3 *This image is a fictional depiction and does not represent an actual weight-loss outcome The proof is in the progress Since starting the program in July, Ive steadily lost more than 10% of my body weight

How does genetic testing help choose between semaglutide and other GLP-1 options

Changes in the epithelial glycoprotein O -acetylated sialic acids associated with ulceration

Samblas, M., Milagro, F

More GLP-1 was needed to achieve the same biological effect, indicating the participants were GLP-1-resistant